Artigo Revisado por pares

Liposomal drug delivery

1996; Elsevier BV; Volume: 1; Issue: 5 Linguagem: Inglês

10.1016/s1359-0294(96)80103-8

ISSN

1879-0399

Autores

Theresa M. Allen,

Tópico(s)

RNA Interference and Gene Delivery

Resumo

Recently, liposomal drug delivery systems have come of age, with three antifungal and two anticancer preparations having received final approval for clinical use in a number of countries around the world. A number of other liposomal formulations of drugs, including anticancer, antibacterial and anti-inflammatory drugs, are in early-to-late clinical trials. Ligand- and antibody-targeted applications, designed to further increase site-specific delivery of liposomal drugs, are currently being explored in a number of laboratories.

Referência(s)